316 related articles for article (PubMed ID: 24939936)
21. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis.
Isidro-Hernández M; Mayado A; Casado-García A; Martínez-Cano J; Palmi C; Fazio G; Orfao A; Ribera J; Ribera JM; Zamora L; Raboso-Gallego J; Blanco O; Alonso-López D; De Las Rivas J; Jiménez R; García Criado FJ; García Cenador MB; Ramírez-Orellana M; Cazzaniga G; Cobaleda C; Vicente-Dueñas C; Sánchez-García I
Sci Rep; 2020 Nov; 10(1):19189. PubMed ID: 33154497
[TBL] [Abstract][Full Text] [Related]
23. PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling.
Xue K; Song J; Yang Y; Li Z; Wu C; Jin J; Li W
Mol Immunol; 2016 May; 73():1-9. PubMed ID: 27016671
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
[TBL] [Abstract][Full Text] [Related]
25. The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.
Schinnerl D; Fortschegger K; Kauer M; Marchante JR; Kofler R; Den Boer ML; Strehl S
Blood; 2015 Feb; 125(8):1282-91. PubMed ID: 25515960
[TBL] [Abstract][Full Text] [Related]
26. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
[TBL] [Abstract][Full Text] [Related]
27. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
Wang Z; Medrzycki M; Bunting ST; Bunting KD
Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
[TBL] [Abstract][Full Text] [Related]
28. Ph-like acute lymphoblastic leukemia with a novel PAX5-KIDINS220 fusion transcript.
Sakamoto K; Imamura T; Kanayama T; Yano M; Asai D; Deguchi T; Hashii Y; Tanizawa A; Ohshima Y; Kiyokawa N; Horibe K; Sato A
Genes Chromosomes Cancer; 2017 Apr; 56(4):278-284. PubMed ID: 27870151
[TBL] [Abstract][Full Text] [Related]
29. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
Nebral K; Denk D; Attarbaschi A; König M; Mann G; Haas OA; Strehl S
Leukemia; 2009 Jan; 23(1):134-43. PubMed ID: 19020546
[TBL] [Abstract][Full Text] [Related]
30. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
Nasr MR; Rosenthal N; Syrbu S
Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
[TBL] [Abstract][Full Text] [Related]
31. Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene.
Sekine R; Kitamura T; Tsuji T; Tojo A
Int J Hematol; 2008 May; 87(4):351-362. PubMed ID: 18415655
[TBL] [Abstract][Full Text] [Related]
32. Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.
Jung M; Schieck M; Hofmann W; Tauscher M; Lentes J; Bergmann A; Stelter M; Möricke A; Alten J; Schlegelberger B; Schrappe M; Zimmermann M; Stanulla M; Cario G; Steinemann D
Genes Chromosomes Cancer; 2020 Nov; 59(11):667-671. PubMed ID: 32592278
[TBL] [Abstract][Full Text] [Related]
33. Pax5: a master regulator of B cell development and leukemogenesis.
Medvedovic J; Ebert A; Tagoh H; Busslinger M
Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
[TBL] [Abstract][Full Text] [Related]
34. The PAX5-JAK2 translocation acts as dual-hit mutation that promotes aggressive B-cell leukemia via nuclear STAT5 activation.
Jurado S; Fedl AS; Jaritz M; Kostanova-Poliakova D; Malin SG; Mullighan CG; Strehl S; Fischer M; Busslinger M
EMBO J; 2022 Apr; 41(7):e108397. PubMed ID: 35156727
[TBL] [Abstract][Full Text] [Related]
35. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
[TBL] [Abstract][Full Text] [Related]
36. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
Gu Z; Churchman ML; Roberts KG; Moore I; Zhou X; Nakitandwe J; Hagiwara K; Pelletier S; Gingras S; Berns H; Payne-Turner D; Hill A; Iacobucci I; Shi L; Pounds S; Cheng C; Pei D; Qu C; Newman S; Devidas M; Dai Y; Reshmi SC; Gastier-Foster J; Raetz EA; Borowitz MJ; Wood BL; Carroll WL; Zweidler-McKay PA; Rabin KR; Mattano LA; Maloney KW; Rambaldi A; Spinelli O; Radich JP; Minden MD; Rowe JM; Luger S; Litzow MR; Tallman MS; Racevskis J; Zhang Y; Bhatia R; Kohlschmidt J; Mrózek K; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Evans WE; Jeha S; Pui CH; Yang J; Paietta E; Downing JR; Relling MV; Zhang J; Loh ML; Hunger SP; Mullighan CG
Nat Genet; 2019 Feb; 51(2):296-307. PubMed ID: 30643249
[TBL] [Abstract][Full Text] [Related]
37. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
Vegliante MC; Palomero J; Pérez-Galán P; Roué G; Castellano G; Navarro A; Clot G; Moros A; Suárez-Cisneros H; Beà S; Hernández L; Enjuanes A; Jares P; Villamor N; Colomer D; Martín-Subero JI; Campo E; Amador V
Blood; 2013 Mar; 121(12):2175-85. PubMed ID: 23321250
[TBL] [Abstract][Full Text] [Related]
38. Paired box gene 5 isoforms A and B have different functions in transcriptional regulation of B cell development-related genes in immature B cells.
Kikuchi H; Nakayama M; Kuribayashi F; Mimuro H; Imajoh-Ohmi S; Nishitoh H; Takami Y; Nakayama T
Microbiol Immunol; 2015 Jul; 59(7):426-31. PubMed ID: 26094714
[TBL] [Abstract][Full Text] [Related]
39. Transcription factor dose links development to disease.
Sigvardsson M
Blood; 2012 Nov; 120(18):3630-1. PubMed ID: 23118213
[No Abstract] [Full Text] [Related]
40. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
